SARS-CoV-2 3CLpro-IN-14 (11j) is a potent, orally bioavailable inhibitor targeting the SARS-CoV-2 3CL protease. It exhibits strong antiviral activity in vitro with an EC50 of 0.18 µM in Vero E6 cells and demonstrates high selectivity (CC50 >50 µM). This compound is a valuable tool for researching coronavirus replication mechanisms and developing antiviral therapies.
Molecular Weight:
735.84
Formula:
C34H40F3N5O6S2
Target:
SARS-CoV
* VAT and and shipping costs not included. Errors and price changes excepted
